C

Cyclacel Pharmaceuticals
D

CYCC

0.34000
USD
-0.01
(-2.86%)
مغلق
حجم التداول
2,687
الربح لكل سهم
-3
العائد الربحي
-
P/E
-0
حجم السوق
2,137,650
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    A
    ADMP
    0
    (0%)
    0.000000 USD
    A
    AVXL
    -0.57500
    (-7.17%)
    7.45000 USD
    C
    CLRB
    -0.14500
    (-7.23%)
    1.86000 USD
    C
    CTIC
    0.11000
    (2.54%)
    4.44000 USD
    D
    DCTH
    0.14000
    (1.52%)
    9.37000 USD
    I
    INFI
    -0.046100
    (-55.54%)
    0.036900 USD
    P
    PTN
    -0.11800
    (-11.03%)
    0.95200 USD
    S
    SLS
    0.03000
    (2.34%)
    1.31000 USD
    المزيد
الأخبار

العنوان: Cyclacel Pharmaceuticals

القطاع: Healthcare
الصناعة: Biotechnology
Cyclacel Pharmaceuticals Inc is a clinical-stage biopharmaceutical company that develops targeted medicines for cancer and other proliferative diseases. The company develops several families of anticancer drugs that act on the cell cycle, including CDK (cyclin-dependent kinase) inhibitors, and PLK (polo-like kinase) inhibitors. The pipeline development programs of the company include fadraciclib, Sapacitabine, and plogosertib.